Obesity paradox, cachexia, frailty, and heart failure

Heart Failure Clinics

Volumn 10, Issue 2, 2014, Pages 319-326

  Lavie, Carl J ^a,b   De Schutter, Alban ^a   Alpert, Martin A ^c   Mehra, Mandeep R ^d   Milani, Richard V ^a   Ventura, Hector O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c University of Missouri   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cachexia; Frailty; Heart failure; Obesity

Indexed keywords

BODY FAT; BODY MASS; CACHEXIA; EXERCISE; HEART FAILURE; HEART FUNCTION; HEART PERFORMANCE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; OBESITY; PREVALENCE; REVIEW; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; COMPLICATION; HEALTH STATUS; PATHOPHYSIOLOGY; PROGNOSIS;

CACHEXIA; HEALTH STATUS; HEART FAILURE; HUMANS; OBESITY; PROGNOSIS;

EID: 84896333678     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.12.002     Document Type: Review

References (45)

1. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. JAm Coll Cardiol 2009, 53:1925-1932.
2. Lavie C.J., Alpert M.A., Arena R., et al. Impact of obesity and the and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013, 1(2):93-102.
3. McNallan S.M., Singh M., Chamberlain A.M., et al. Frailty and healthcare utilization among patients with heart failure in the community. JAm Coll Cardiol 2013, 1(2):135-141.
4. Mehra M.R. Fat, cachexia and the right ventricle in heart failure. JAm Coll Cardiol 2013, 62(18):1671-1673.
5. Melenovsky V., Kotrc M., Borlaug B.A., et al. Relationships between right ventricular function, body composition and prognosis in advanced heart failure. JAm Coll Cardiol 2013, 62(18):1660-1670.
6. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and the risk of heart failure. NEngl J Med 2002, 347:305-313.
7. Alpert M.S., Terry B.E., Mulekar M., et al. Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure and effect of weight loss. Am J Cardiol 1997, 80:736-740.
8. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. The relationship between obesity and mortality in patients with heart failure. JAm Coll Cardiol 2001, 38:789-795.
9. Lavie C.J., Osman A.F., Milani R.V., et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003, 91:891-894.
10. Clark A.L., Chyu J., Horwich T.B. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 2012, 110:77-82.
11. Fonarow G.C., Srikanthan P., Costanzo M.R., et al. An obesity paradox in acute heart failure: analysis of body mass index and in hospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007, 153:74-81.
12. Kenchaiah S., Pocock S.J., Wang D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation 2007, 116:627-636.
13. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
14. Mohamed-Ali V., Goodrick S., Bulmer K., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue invivo. Am J Physiol 1999, 277:E971-E975.
15. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 2000, 356:930-933.
16. Mehra M.R., Uber P.A., Parh M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. JAm Coll Cardiol 2004, 43:1590-1595.
17. Kaminsky L.A., Arena R., Beckie T.M., et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation 2013, 127(5):652-662.
18. Artero E.G., Lee D.C., Lavie C.J., et al. Effects of muscular strength on cardiovascular risk factors and prognosis. JCardiopulm Rehabil Prev 2012, 32:351-358.
19. Nagarajan V., Cauthern C.A., Starling R.C., et al. Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 2013, 19:160-164.
20. Lavie C.J., Vetura H.O. Analyzing the weight of evidence on the obesity paradox and heart failure - Is there a limit to the madness?. Congest Heart Fail 2013, 19:158-159.
21. Writing Committee Members, Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013, 128(16):e240-e319.
22. Habbu A., Lakkis N.M., Dokainish H. The obesity paradox: fact or fiction?. Am J Cardiol 2006, 98:944-948.
23. Flegal K.M., Kit B.K., Orpana H., et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013, 309:71-82.
24. Azimi A., Charlot M.G., Torp-Pedersen C., et al. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart 2013, 99(9):655-660. 10.1136/heartjnl-2012-303066.
25. Lavie C.K., De Schutter A., Patel D., et al. Body composition and coronary heart disease mortality: an obesity or a lean paradox?. Mayo Clin Proc 2011, 86:857-864.
26. Lavie C.J., De Schutter A., Milani R.V. Is there an obesity, overweight, or lean paradox in coronary disease? Getting to the 'fat' of the matter. Heart 2013, 99(9):596-598.
27. Lavie C.J., De Schutter A., Patel D.A., et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". JAm Coll Cardiol 2012, 60:1374-1380.
28. Lavie C.J., Mehra M.R., Milani R.V. Obesity and heart failure prognosis: paradox or reverse epidemiology?. Eur Heart J 2005, 26(1):5-7.
29. Anker S.D., Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002, 85(1):51-66.
30. Palus S., Schur R., Akashi Y.J., et al. Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 in a rat heart failure model. PLoS One 2011, 6(11):e26865. 10.1371/journal.pone.0026865.
31. Suzuki M., Narita M., Ashikawa M., et al. Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia. Synapse 2012, 66(8):747-751.
32. Stout M., Tew G.A., Doll H., et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am Heart J 2012, 164(6):893-901.
33. Han H.Q., Zhou X., Mitch W.E., et al. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol 2013, 45(10):2333-2347. pii:S1357-2725(13)00163-5. 10.1016/j.biocel.2013.05.019.
34. Mehra M.R., Lavie C.J., Ventura H.O., et al. Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. JHeart Lung Transplant 2006, 25(7):834-838.
35. Lavie C.J., Milani R.V., Mehra M.R., et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. JAm Coll Cardiol 2009, 54(7):585-594.
36. Lavie C.J., De Schutter A., Patel D.A., et al. New insights into the "obesity paradox" and cardiovascular outcomes. JGlycomics Lipidomics 2012, 2:2.
37. Lavie C.J., Swift D.L., Johannsen N.M., et al. Physical fitness-an often forgotten cardiovascular risk factor. JGlycomics Lipidomics 2012, 2:2.
38. McAuley P.A., Artero E.G., Sui X., et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012, 87:443-451.
39. Lavie C.J., Cahalin L.P., Chase P., et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013, 88:251-258.
40. Lavie C.J., De Schutter A., Patel D.A., et al. Does fitness completely explain the obesity paradox?. Am Heart J 2013, 166(1):1-3.
41. Lavie C.J., Berra K., Arena R. Formal cardiac rehabilitation and exercise training programs in heart failure. JCardiopulm Rehabil Prev 2013, 33:209-211.
42. Lavie C.J., Arena R., Earnest C.P. High-intensity interval training in patients with cardiovascular diseases and heart transplantation. JHeart Lung Transplant 2013, 32(11):1056-1058.
43. Piepoli M.F., Davos C., Francis D.P., et al. Exercise Training Meta-analysis of Trials in Patients with Chronic Heart Failure (ExTraMATCH). BMJ 2004, 328(7433):189. ExTraMATCH Collaborative.
44. O'Connor C.M., Whellan D.J., Lee K.L., HF-ACTIONInvestigators, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009, 301:1439-1450.
45. Keteyian S.J., Leifer E.S., Houston-Miller N., HF-ACTION Investigators, et al. Relation between volume of exercise and clinical outcomes in patients with heart failure. JAm Coll Cardiol 2012, 60(19):601899-601905.